Laboratory – Talk Bio

DOGE Reverses Course on FDA Facility Closures, Including Major St. Louis Quality Lab

4 weeks ago talkbio0Tagged cost-cutting, DOGE, drug quality, Laboratory, Reversal, St. Louis, terminations, United States Food and Drug Administration

DOGE, FDA, lease terminations, St. Louis, drug quality lab, cost-cutting, reversal

AI-Driven Enzyme Engineering: Baker Lab’s Latest Breakthrough in Computational Protein Design

2 months ago talkbio0Tagged AI-generated, artificial luciferases, Baker, Biochemistry, computational protein design, enzyme engineering, Enzymes, Laboratory, Machine Learning, Universities, Washington state

AI-generated enzymes, computational protein design, artificial luciferases, de novo enzyme engineering, machine learning in biochemistry, Baker Lab, University of Washington

FDA Rejects Atara’s Ebvallo Due to Manufacturing Issues, Not Efficacy or Safety Concerns

3 months ago talkbio0Tagged Atara, Ebvallo, Epstein-Barr virus, Laboratory, Pierre, Post-transplant lymphoproliferative disorder, Rejection, T-cell immunotherapy, United States Food and Drug Administration

Atara Therapeutics, Ebvallo, FDA rejection, manufacturing issues, post-transplant lymphoproliferative disease (PTLD), Epstein-Barr virus (EBV), T-cell immunotherapy, Pierre Fabre Laboratories.

Pfizer and PostEra Expand AI-Driven Drug Discovery Partnership to Include Antibody-Drug Conjugates (ADCs)

4 months ago talkbio0Tagged Antibody-Drug, Antibody-Drug Conjugates, Aortic Valve Insufficiency, Chemistry, Pharmaceutical, Drug Discovery, Immunostimulating conjugate (antigen), Laboratory, Pfizer, Pfizer/, PostEra, Proton Platform, Small Molecule

AI-driven drug discovery, Antibody-Drug Conjugates (ADCs), Pfizer, PostEra, AI Lab, Proton platform, small molecule therapeutics, medicinal chemistry.